Indivior: Still Attractive After FY25 Earnings Beat [Seeking Alpha]
Indivior PLC (INDV)
Company Research
Source: Seeking Alpha
INDV remains a 'buy' at a $3.7bn market cap, with management targeting 8% Sublocade sales growth in 2026 and 48% adj. EBITDA margins. Valuation is attractive at sub-10x NTM EV/EBITDA and a 10% FCF yield, with a $400m buyback approved for 2026–2027. Key risks include high patient attrition, concentrated OUD exposure, and vulnerability to insurance or medicaid funding changes. Conservatively see upside potential of 30%+ in equity value without considering buyback programme. Rabbitti/iStock via Getty Images Introduction I previously covered Indivior ( INDV ) when the market had become extremely bearish on the name back in October 2024 . At the time, the company traded at sub-$10 per share and had a
Show less
Read more
Impact Snapshot
Event Time:
INDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INDV alerts
High impacting Indivior PLC news events
Weekly update
A roundup of the hottest topics
INDV
News
- Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse [Yahoo! Finance]Yahoo! Finance
- Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication MisuseGlobeNewswire
- Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th GlobeNewswire
- What Indivior Pharmaceuticals (INDV)'s Prison Cost Model Findings Mean For Shareholders [Yahoo! Finance]Yahoo! Finance
- New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional FacilitiesGlobeNewswire
INDV
Earnings
- 2/26/26 - Beat
INDV
Sec Filings
- 3/27/26 - Form ARS
- 3/27/26 - Form DEFA14A
- 3/27/26 - Form DEF
- INDV's page on the SEC website